KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Inventory Average (2021 - 2026)

Moderna (MRNA) has disclosed Inventory Average for 6 consecutive years, with $149.5 million as the latest value for Q1 2026.

  • For Q1 2026, Inventory Average rose 22.04% year-over-year to $149.5 million; the TTM value through Mar 2026 reached $149.5 million, up 22.04%, while the annual FY2025 figure was $135.0 million, 15.36% down from the prior year.
  • Inventory Average hit $149.5 million in Q1 2026 for Moderna, down from $242.5 million in the prior quarter.
  • Across five years, Inventory Average topped out at $2.0 billion in Q3 2022 and bottomed at $122.5 million in Q1 2025.
  • Average Inventory Average over 5 years is $699.7 million, with a median of $347.0 million recorded in 2024.
  • Year-over-year, Inventory Average surged 525.32% in 2022 and then plummeted 77.23% in 2023.
  • Moderna's Inventory Average stood at $1.5 billion in 2022, then tumbled by 77.23% to $344.5 million in 2023, then fell by 23.22% to $264.5 million in 2024, then dropped by 8.32% to $242.5 million in 2025, then crashed by 38.35% to $149.5 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods came in at $149.5 million, $242.5 million, and $286.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.